Cited by 446Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Scheff, Stephen W., DeKosky, Steven T., Price, Douglas A.·1990·Neurobiology of Aging

DOI 10.1016/0197-4580(90)90059-9

Open this paper in CoChat — free account

Abstract

Significant progress has been made over the last decade in delineating the neuropathological and neurochemical changes in the brains of patients with Alzheimer's disease (AD). Less well studied are the actual synaptic connections of affected areas of the brain, such as the cerebral cortex. Because the final common pathway for neurotransmission involves synaptic integrity, we quantitatively assessed synaptic number and synapse size in lamina III and V of human frontal cortex (Brodmann area 9) in patients with AD and age-matched controls. Samples were also matched for postmortem interval, and artifacts associated with postmortem change were eliminated. We found a significant decrease in synaptic number per unit volume in both lamina, more marked in lamina III (-42%) than V (-29%). In both normal controls and AD brains, there was a negative correlation between synapse number and synapse size as indexed by the length of the postsynaptic density (PSD); cortical samples with fewer synapses had larger synapse size. This appeared to be a compensatory response, rather than a selective loss of small synapses, since the total amount of synaptic contact area per unit volume did not decline in lamina V (despite a 29% loss of synapses); in lamina III it was reduced 11% despite a 42% loss of synapses. The loss of synapses in AD is widespread and significant in frontal cortex; there is observable compensation by enlargement of synaptic size. This compensatory effort is overcome by the continuing loss of synapses in areas most affected by the degeneration.

Integrity signals

Registry

Crossref · 10.1016/0197-4580(90)90059-9

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C. S., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,416
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801

Show all 41 references

Sorted by citations

Items 301–400 of 445

LETTER TO THE EDITOR. Hippocampal Atrophy Measurement in Alzheimer?s Disease
Frisoni, G. B., Trabucchi, M., & Beltramello, A. (1996) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199601)11:1 · Cited by 3
Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-l-carnitine administration
Bertoni–Freddari, C., Fattoretti, P., Casoli, T., Spagna, C., & Casell, U. (1994) · Brain Research · doi:10.1016/0006-8993(94)91480-x · Cited by 17
Long‐term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis
Orciani, C., Hall, H., Pentz, R., Foret, M. K., Carmo, S. D., & Cuello, A. C. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15683 · Cited by 16
Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice
Moon, M., Choi, J. G., Kim, S. Y., & Oh, M. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140270 · Cited by 16
Protein Kinases and Growth Associated Proteins in Plaque Formation in Alzheimer's Disease
Masliah, E., Mallory, M. E., Ge, N., & Saitoh, T. (1992) · Reviews in the Neurosciences · doi:10.1515/revneuro.1992.3.2.99 · Cited by 16
Early Dendritic Dystrophy in Human Brains With Primary Age-Related Tauopathy
Shi, Y., Tu, T., Jiang, J., Zhang, Q., Ai, J.-Q., Pan, A., Manavis, J., Tu, E., & Yan, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.596894 · Cited by 14
Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., & Ye, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999024 · Cited by 15
miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons
Shvarts-Serebro, I., Sheinin, A., Gottfried, I., Adler, L., Schottlender, N., Ashery, U., & Barak, B. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01862-2 · Cited by 15
Abnormalities in Non-Cholinergic Neurotransmitter Systems in Alzheimer’s Disease
Dewar, D., & McCulloch, J. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_11 · Cited by 15
Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer’s Disease
Mi, Z., Abrahamson, E. E., Ryu, A. Y., Malek‐Ahmadi, M. H., Kofler, J., Fish, K. N., Sweet, R. A., Villemagne, V. L., Schneider, J. A., Mufson, E. J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221063 · Cited by 15
Invited Review – A 5‐year update on epigenome‐wide association studies of DNA modifications in Alzheimer’s disease: progress, practicalities and promise
Smith, A. R., Wheildon, G., & Lunnon, K. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12650 · Cited by 14
Morphometric image analysis of neuropil threads in alzheimer's disease
Markesbery, W. R., Wang, H. Z., Kowall, N. W., Kosik, K. S., & McKee, A. C. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90115-r · Cited by 15
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease
Massa, F., Martinuzzo, C., José, N. G. D. S., Pelagotti, V., Kreshpa, W., Abu‐Rumeileh, S., Barba, L., Mattioli, P., Orso, B., Brugnolo, A., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12154-7 · Cited by 16
What Goes Up Must Come Down: Homeostatic Synaptic Plasticity Strategies in Neurological Disease
André, E. A., Forcelli, P. A., & Pak, D. T. S. (2018) · Future Neurology · doi:10.2217/fnl-2017-0028 · Cited by 15
Downregulation of PIK3CB Involved in Alzheimer’s Disease via Apoptosis, Axon Guidance, and FoxO Signaling Pathway
Zhou, Z., Bai, J., Zhong, S., Zhang, R., Kang, K., Zhang, X., Xu, Y., Zhao, C., & Zhao, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1260161 · Cited by 12
Neurodegeneration in the cortical sulcus is a feature of chronic traumatic encephalopathy and associated with repetitive head impacts
Nicks, R., Shah, A., Stathas, S., Kirsch, D. A., Horowitz, S. M., Saltiel, N. A., Calderazzo, S. M., Butler, M. L. M. D., Cormier, K., Aytan, N., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02833-8 · Cited by 14
AD molecular: Molecular imaging of Alzheimer's disease: PET imaging of neurotransmitter systems
Mecca, A. P. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.04.003 · Cited by 13
[3H]Phorbol ester binding sites and neuronal plasticity in the hippocampus following entorhinal cortex lesions
Parent, A., Dea, D., Quirion, R., & Poirier, J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91485-b · Cited by 12
Microglial double stranded DNA accumulation induced by DNase II deficiency drives neuroinflammation and neurodegeneration
Li, L.-J., Liang, S., Sun, X., Zhu, J., Niu, X.-Y., Du, X.-Y., Huang, Y., & Liu, R. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03333-6 · Cited by 14
Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500
Lo, A. C., Tesseur, I. C., Scopes, D. I. C., Nerou, E., Callaerts‐Vegh, Z., Vermaercke, B., Treherne, J. M., Strooper, B. D., & D’Hooge, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.030 · Cited by 11
Pathological Diagnosis of Alzheimer’s Disease
Geula, C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_3 · Cited by 11
Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease
Mecca, A. P., Ashton, N. J., Chen, M., O’Dell, R. S., Toyonaga, T., Zhao, W., Young, J. J., Salardini, E., Bates, K. A., Ra, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70344 · Cited by 10
Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment
Cai, S., Huang, K., Yang, F., Wang, X., Wu, S., Wang, Y., & Huang, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.745381 · Cited by 11
Vascular Dementia: A Cognitive SPET-CBF Activation Study
Piero, V. D., Giannini, M., Bragoni, M., Vicenzini, E., Legge, S. D., Altieri, M., Pantano, P., & Lenzi, G. L. (2001) · Cerebrovascular Diseases · doi:10.1159/000047681 · Cited by 10
Structural correlates and cellular mechanisms in entorhinal—hippocampal dysfunction
Schousboe, A., Bachevalier, J., Braak, H., Heinemann, U., Nitsch, R., Schröder, H., & Wetmore, C. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030732 · Cited by 10
Vascular Dementia: Pathological Findings
Brun, A. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_40 · Cited by 10
Sustained cortical metabolic responsivity to physostigmine after nucleus basalis magnocellularis ablation in rats
Micheli, E. D., Lamour, Y. A., Bassant, M., & Soncrant, T. T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91116-a · Cited by 10
Advances and Challenges in Gene Therapy for Alzheimer’s Disease
Morroni, F., & Caccamo, A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230783 · Cited by 11
A computational grid-to-place-cell transformation model indicates a synaptic driver of place cell impairment in early-stage Alzheimer’s Disease
Ness, N., & Schultz, S. R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009115 · Cited by 8
Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment
Boutté, A. M., Neely, M. D., Bird, T. D., Montine, K. S., & Montine, T. J. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8101 · Cited by 9
The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.
Shen, J., Wang, D., & Wang, R. (2012) · PubMed Central · Cited by 9
Changes in the Sensitivity of Frontal Cortical Neurones to Acetylcholine After Unilateral Lesion of the Nucleus Basalis with α-Amino-3-OH-4-Isoxozole Propionic Acid (AMPA): Effects of Basal Forebrain Transplants Into Neocortex
Abdulla, F. A., Calaminici, M., Gray, J. A., Sinden, J. D., & Stephenson, J. D. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(96)00213-4 · Cited by 9
Gene Expression Studies on Human Trisomy 21 iPSCs and Neurons: Towards Mechanisms Underlying Down’s Syndrome and Early Alzheimer’s Disease-Like Pathologies
Weick, J. P., Kang, H., Bonadurer, G. F., & Bhattacharyya, A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_15 · Cited by 9
The role of the Pin1-cis P-tau axis in the development and treatment of vascular contribution to cognitive impairment and dementia and preeclampsia
Qiu, C., Li, Z., Leigh, D. A., Duan, B., Stucky, J. E., Kim, N., Xie, G., Lu, K. P., & Zhou, X. Z. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1343962 · Cited by 9
Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer’s disease: a multi-tracer PET study
Salardini, E., O’Dell, R. S., Tchorz, E., Nabulsi, N., Huang, Y. H., Carson, R. E., van Dyck, C. H., & Mecca, A. P. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01739-1 · Cited by 8
Antiviral Immune Response in Alzheimer’s Disease: Connecting the Dots
Roy, E. R., & Cao, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.577744 · Cited by 8
Morphological Changes in Human Cerebral Cortex during Normal Aging
Bussière, T., & Hof, P. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50009-3 · Cited by 8
NGF-induced neurite outgrowth of PC12 cells in the presence of phosphatidylcholine hydroperoxides: Implication for ageing
Yamanaka, Y., Yoshida, S., & Doi, H. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.008 · Cited by 8
Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer’s Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice
Li, K., Jiang, Y., Li, G., Liu, T., & Yang, Z. R. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00574 · Cited by 8
Strategizing the Development of Alzheimer’s Therapeutics
Davis, J. B., & Couch, R. D. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.33011 · Cited by 7
Synaptic loss in anterior horn neurons in lower motor neuron disease
Sasaki, S., & Iwata, M. (1996) · Acta Neuropathologica · doi:10.1007/s004010050444 · Cited by 7
Cholinergic Neurotransmission, Amyloid-β Peptide and the Pathogenesis of Alzheimer's Disease
Liu, L. (2003) · Cited by 7
CLARITY increases sensitivity and specificity of fluorescence immunostaining in long-term archived human brain tissuePreprint
Woelfle, S., Deshpande, D., Feldengut, S., Roselli, F., Deisseroth, K. A., Michaelis, J., Boeckers, T. M., & Schön, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.27.489700 · Cited by 7
Differences in inflammatory markers, mitochondrial function, and synaptic proteins in male and female Alzheimer's disease post mortem brains
Yang, A. J. T., Mohammad, A., Crozier, R. W. E., Maddalena, L. G., Tsiani, E., Adam, J. M., Spencer, G. E., Necakov, A., Duarte‐Guterman, P., Stuart, J. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70645 · Cited by 6
Transient elevation of synaptosomal mitoenergetic proteins and Hsp70 early in a rat model of chronic cerebrovascular hypoperfusion
Zhang, H. N., Wu, J., Jin, T., Chang, M. J. W., & Sun, L. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1063-4 · Cited by 6
Loss and microglia phagocytosis of synaptic proteins in frontotemporal lobar degeneration with TDP-43 proteinopathy
Ayala, I. A. D. L., Bahrami, A., Pan, Y., Spencer, C., Flanagan, M. E., Mesulam, M. M., Gefen, T. D., & Geula, C. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105719 · Cited by 6
Relationship of plaques and tangles to Alzheimer's disease phenotype
Morris, J. C. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50013-3 · Cited by 6
Morphological Alterations of Synaptic Mitochondria during Aging
Bertoni–Freddari, C., Fattoretti, P., Casoli, T., Spagna, C., & Meier-Ruge, W. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb12081.x · Cited by 6
A synaptic-astrocytic proteomic signature associated with synaptopathy in Alzheimer’s DiseasePreprint
Griffiths, J., Schneegans, E., Whitwell, H. J., Qiu, Z., Notman, B., Cheung, T. K. D., Willumsen, N., Matthews, P. M., Grant, S. G. N., & Jackson, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.23.634408 · Cited by 7
Polygenic Hazard Score Associated Multimodal Brain Networks Along the Alzheimer’s Disease Continuum
Li, K., Fu, Z., Qi, S., Luo, X., Zeng, Q., Xu, X., Huang, P., Zhang, M., & Calhoun, V. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.725246 · Cited by 5
APP family member dimeric complexes are formed predominantly in synaptic compartments
Schilling, S., August, A., Meleux, M., Conradt, C., Tremmel, L. M., Teigler, S., Adam, V., Müller, U., Koo, E. H., Kins, S., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01092-6 · Cited by 6
Neuropeptide Changes in Cortical and Deep Gray Structures in Alzheimer's Disease
Roeske, L. C., & Auchus, A. P. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.317 · Cited by 5
Neuropathological Correlates of Dementia in Alzheimer’s Disease
Masliah, E., & Salmon, D. P. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_15 · Cited by 5
Brain tissue microarrays in neurodegenerative diseases: Validation of methodology and immunohistochemical study of growth‐associated protein‐43 and calretinin
Takei, H., Buckleair, L. W., Rivera, A. L., & Powell, S. Z.-E. (2007) · Pathology International · doi:10.1111/j.1440-1827.2007.02173.x · Cited by 5
FK960, a potential anti-dementia drug, increases synaptic density in the hippocampal CA3 region of aged rats
Moriguchi, A., Nakano, K., Yamaguchi, I., Sano, K., Kosei, N. O. D. A., Hashimoto, M., Ohara, K., Matsuoka, N., & Goto, T. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03686-7 · Cited by 5
Cholinergic Changes and Synaptic Alterations in Alzheimer’s Disease
DeKosky, S. T., Styren, S. D., & O’Malley, M. E. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_16 · Cited by 5
The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
Bouter, Y. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4849 · Cited by 5
Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention
Li, X., Wan, R., Zhao, Y., Wu, Y., Chen, X., Li, Q., & Luo, C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103028 · Cited by 7
Influence of metabolic stress and metformin on synaptic protein profile in SH‐SY5Y‐derived neurons
Yang, A. J. T., Mohammad, A., Finch, M. S., Tsiani, E., Spencer, G. E., Necakov, A., & MacPherson, R. E. K. (2023) · Physiological Reports · doi:10.14814/phy2.15852 · Cited by 3
Experimental evidence that readily diffusible forms of Aβ from Alzheimer’s disease brain have seeding activity
Song, S., Liu, Q., Chen, R., Chen, P., Tao, M., Li, S., Guo, L., Zhu, X., Liu, Y., Liu, L., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02032-w · Cited by 5
Synaptic protein CSF levels relate to memory scores in individuals without dementia
Wesenhagen, K. E. J., de Leeuw, D. M., Tomassen, J., Gobom, J., Bos, I., Vos, S. J. B., Martínez‐Lage, P., Tainta, M., Popp, J., Peyratout, G., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01703-z · Cited by 4
Gender differences in cell volume fraction (CVF): a structural parameter reflecting the energy efficiency of maintaining the resting membrane potential
Thulborn, K. R. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4693 · Cited by 4
Cerebrospinal Biomarkers in Alzheimer Disease—Potential Roles as Markers of Prognosis and Neuroplasticity
DeKosky, S. T., & Golde, T. E. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0090 · Cited by 4
Association of APOC1 with cortical atrophy during conversion to Alzheimer’s disease
Oh, S., Kim, S., Kim, J. P., Seo, S. W., Park, B.-Y., & Park, H. (2025) · GeroScience · doi:10.1007/s11357-025-01695-6 · Cited by 4
Alzheimer's disease: a neuropathologic perspective
Vinters, H. (1998) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(98)80019-7 · Cited by 2
Effects of Aging on the Human Nervous System
de la Torre, J. C., & Fay, L. A. (2001) · Springer eBooks · doi:10.1007/978-1-4757-3432-4_64 · Cited by 3
Synaptic plasticity in Alzheimer's disease
Terry, R. D. (1993) · Annals of Neurology · doi:10.1002/ana.410340302 · Cited by 3
A History of the Morphology of Alzheimer’s Disease
Terry, R. D. (2019) · CRC Press eBooks · doi:10.1201/9780429260353-5 · Cited by 3
3D analysis of the synaptic organization in the Entorhinal cortex in Alzheimer’s diseasePreprint
Domínguez-Álvaro, M., Montero‐Crespo, M., Blázquez‐Llorca, L., Plaza‐Alonso, S., Cano‐Astorga, N., DeFelipe, J., & Alonso‐Nanclares, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.19.345025 · Cited by 3
Editorial: The Molecular Mechanisms of Synaptic Plasticity Impairments in Alzheimer’s Disease
Liu, G., Lei, P., Dong, Z., & Li, S.-P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.832728 · Cited by 3
Mapping Alzheimer’s Molecular Pathologies in Large-Scale Connectomics Data: A Publicly Accessible Correlative Microscopy ResourcePreprint
Han, X., Li, P. H., Wang, S., Blakely, T. M., Aggarwal, S., Gopalani, B., Sanchez, M., Schalek, R. L., Meirovitch, Y., Lin, Z., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563674 · Cited by 3
Research progress in neuroimaging of sporadic early-onset Alzheimer’s disease
Zhang, X., & Yang, C. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1788814 · Cited by 2
Modelling Cortical and Thalamocortical Synaptic Loss and Compensation Mechanisms in Alzheimer’s Disease
Coyle, D., Abuhassan, K., & Maguire, L. (2015) · Springer series in computational neuroscience · doi:10.1007/978-3-319-20037-8_9 · Cited by 2
Lipid Peroxidation and Age-Related Neurodegenerative Disorders
Spickett, C., & Forman, H. (2015) · CRC Press eBooks · doi:10.1201/b18138-21 · Cited by 2
Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission
Boccalini, C., Perani, D., & Garibotto, V. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19088-9.00014-7 · Cited by 2
Pin1 Protects Against Alzheimer's Disease: One Goal, Multiple Mechanisms
Pastorino, L., Kondo, A., Zhen, X., & Lu, K. P. (2013) · InTech eBooks · doi:10.5772/55085 · Cited by 2
Synaptic function as a preclinical and experimental medicine readout for disease-modifying therapy in Alzheimer's Disease
Lu, B., Nagappan, G., Nathan, P. J., & Blin, O. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2014.04.001 · Cited by 2
Neural Regeneration as a Disease-Modifying Therapeutic Strategy for Alzheimer’s Disease
Kazim, S. F., & Iqbal, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00002-8 · Cited by 2
Demencias y enfermedad de Alzheimer
Mirete, J. S., Basté, M. C., Gómez, N. C., Pérez, R. C., & Miguel, S. S. (2011) · Elsevier eBooks · doi:10.1016/b978-84-458-2066-7.00018-5 · Cited by 3
The Pathology of Synapses in Brain Networks Implicated in Depression
Bennett, M. R. (2012) · Springer eBooks · doi:10.1007/978-94-007-5748-6_6 · Cited by 2
Liquid–liquid phase separation in synaptopathies
Jiang, H., & Wu, H. (2023) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.21 · Cited by 2
Searching for the holy grail: What is the structural correlate of cognition?
DeKosky, S. T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00011-3 · Cited by 2
Basis of Structural Alzheimer Disease and Some Pathogenic Concepts
Terry, R. D. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_4 · Cited by 2
S14 TRANSGENIC MICE MODELS FOR ALZHEIMER??S DISEASE
LEUVEN, F. V. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00033 · Cited by 2
Molecular Mechanisms of Impaired Mitochondrial Gene Expression in Alzheimer’s Disease
Chandrasekaran, K., Hatanpaa, K. J., Liu, L., & Rapoport, S. I. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9936-1_7 · Cited by 2
Aβ-induced synaptic injury is mediated by presynaptic expression of amyloid precursor protein (APP) in hippocampal neuronsPreprint
Orri, E. V., Kasuga, K., Tyan, S.-H., Chiang, K., da Silva, S. V., Bushong, E. A., DeLoach, K. E., Ling, I., Luo, L., Ellisman, M. H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.18.210344 · Cited by 2
ZCCHC17 knockdown phenocopies Alzheimer’s disease-related loss of synaptic proteins and hyperexcitability
Cortese, G. P., Bartosch, A. M. W., Xiao, H., Gribkova, Y., Lam, T. G., Argyrousi, E. K., Sivakumar, S., Cardona, C. L., & Teich, A. F. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae033 · Cited by 1
Neuronal gene profiling of tau oligomer-bearing cholinergic nucleus basalis neurons during the onset of Alzheimer’s disease
Kara, B., Beck, J. S., Fu, Z., Hickey, S. L., Kanaan, N. M., Mufson, E. J., Ginsberg, S. D., & Counts, S. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02080-2 · Cited by 1
Synaptophysin density underestimates synapse counts in the human brain – An anatomical study on synaptoporin protein expression
Woelfle, S., Schön, M., Pedro, M. T., Wagner, J., Shiban, E., Hong, B., Tsoy, Y., & Boeckers, T. M. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107503 · Cited by 1
Choline Modulation of the Aβ P1-40 Channel Reconstituted into a Model Lipid Membrane
Meleleo, D., Notarachille, G., & Micelli, S. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/752804 · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition
Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1
In vivo neuropil density from anatomical MRI and machine learning
Akif, A., Staib, L. H., Hermán, P., Rothman, D. L., Yu, Y., & Hyder, F. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae200 · Cited by 1
Glutamate Receptors and Excitotoxic Mechanisms in Alzheimer’s Disease
Geddes, J. W. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_18 · Cited by 1
Oxydativer Energiestoffwechsel bei der Demenz vom Alzheimer-Typ
Hoyer, S. (1993) · Springer eBooks · doi:10.1007/978-3-7091-9263-4_92 · Cited by 1
Impaired recognition memory and emotional reactivity associated with loss of cortical integrity in rats after chronic exposure to aluminum
Miu, A. C., Medrea, R. I., Andreescu, C. E., Stancu, I., Vlasie, N., & Olteanu, A. I. (2003) · DIAL (Catholic University of Leuven) · Cited by 1
Use or abuse
Scheff, S. W. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90019-g · Cited by 1
Detection and Analysis of Synaptosis
Cole, G. M., & Gylys, K. H. (2002) · Neuromethods · doi:10.1385/1-59259-188-4:177 · Cited by 1
Developing an Alzheimer’s Disease Therapeutic: Identification and Validation of Signaling Pathways Involved in Small Molecule Induction of Nerve Growth Factor
Davis, J. B. (2016) · doi:10.13021/mars/7006 · Cited by 1
A History of the Morphology of Alzheimer's Disease
Terry, R. D. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch3 · Cited by 1

Authors: Scheff, S. W., DeKosky, S. T., & Price, D. A.
Affiliations: University of Kentucky (US)
Corresponding author: Scheff, Stephen W.
ORCID: DeKosky, Steven T.
Price, Douglas A.
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 1990-01
Volume: 11
Issue: 1
Pages: 29-37
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/0197-4580(90)90059-9
OpenAlex: W2083752135
Cited by: 446
References: 41
Citations by year: 2026: 7 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 16 · 2021: 14 · 2020: 19 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 17 · 2015: 21 · 2014: 13 · 2013: 16 · 2012: 16
FWCI: 9.93
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Funders: University of Kentucky
National Institute on Aging (P50AG005144, AG-05144, P01AG005119, AG0 5119)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: Alzheimer's disease, synaptic density, synapse size, postsynaptic density, frontal cortex, Brodmann area 9, cortical layers, synaptic loss, postmortem interval, neuropathology
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Cell Count, Cerebral Cortex, Female, Humans, Male, Middle Aged, Nerve Degeneration, Synapses, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Quantitative assessment of cortical synaptic density in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks